MedTrace Logo

Developing a Exercise Program for Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT06907004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2025-04-02

No results posted yet for this study

Summary

Background: Hematopoietic stem cell transplantation (HSCT) is a highly aggressive treatment, which is associated with numerous treatment-related side effects, such as fatigue and decreased functional activity. While recent studies have shown that physical exercise for patients undergoing HSCT is safe and feasible, and has a positive effect on the quality of life, fatigue, and lower limb muscle strength. However, there is no consensus regarding the intensity, type and frequency of exercise program, and few studies mention the patients' experience of exercise barriers and facilitators during HSCT. Therefore, the clinical implementation of exercise program is quite difficult.

Purpose: The purpose of this study is to develop a feasible exercise program for hospitalized patients undergoing hematopoietic stem cell transplantation.

Methods: Action Research is used to collect quantitative and qualitative data. Through the rolling revision of the exercise program during HSCT, finally develop a feasible exercise program.

Expected results: Developing a feasible exercise program for hospitalized patients undergoing hematopoietic stem cell transplantation.

Conditions

  • Hematopoietic Stem Cell Transplantation

Sponsors & Collaborators

  • Chimei Medical Center

    lead OTHER

Principal Investigators

  • Min-Syuan Yen, Master's Degree · Chimei Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2023-10-13
Completion
2023-10-13

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06907004 on ClinicalTrials.gov